Nodal response to primary systemic therapy predicts prognosis of cN3c breast cancer patients receiving multimodality therapy

AIM: To investigate the survival outcomes, patterns and risks of recurrence in cN3c breast cancer patients after multimodality therapy, as well as the predictors of candidates for ipsilateral supraclavicular (SCV) area boosting. METHOD: Consecutive cN3c breast cancer patients from January 2009 to De...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuyan, Qi, Weixiang, Cao, Lu, Xu, Cheng, Cai, Rong, Chen, Jiayi, Cai, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344941/
https://www.ncbi.nlm.nih.gov/pubmed/37423063
http://dx.doi.org/10.1016/j.breast.2023.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344941/
https://www.ncbi.nlm.nih.gov/pubmed/37423063
http://dx.doi.org/10.1016/j.breast.2023.06.008

Ejemplares similares